Tag Archives: Wakix

Harmony Bio and Inhibrx Raise Combined $247M in Public Market Debuts

Two biotechs this week topped the $100 million mark in their respective initial public offerings, both of which were able to offer more shares than planned. One, a company with nearly nine month’s-worth of revenue from a newly commercialized drug and the other, an early-clinical stage oncology drug developer, illustrate the range of biotech companies […]

Posted in National, National blog main, National top stories, Philadelphia Blog Main, Philadelphia Top stories, San Diego blog main, San Diego top stories | Tagged , , , , , , , , , , , , , , | Comments Off on Harmony Bio and Inhibrx Raise Combined $247M in Public Market Debuts

Jazz Pharma Gets FDA Nod for New Drug to Treat Narcolepsy Symptoms

[Corrected 7/23/20, 10:13 am. See below.] Jazz Pharmaceuticals has received FDA approval for a narcolepsy drug that it has developed as a lower-sodium successor to its biggest moneymaker, a treatment that was first approved in 2002 to reduce attacks of muscle weakness associated with the disease. That drug, sodium oxybate (Xyrem), was first OK’d to reduce […]

Posted in Europe, Europe blog main, Europe top stories, National blog main, National top stories, Philadelphia Blog Main, San Francisco blog main | Tagged , , , , , , , , , , , | Comments Off on Jazz Pharma Gets FDA Nod for New Drug to Treat Narcolepsy Symptoms